Human Sal-like protein 4(SALL4) ELISA kit
-
中文名称:人Sal样蛋白4(SALL4)酶联免疫试剂盒
-
货号:CSB-EL020676HU
-
规格:96T/48T
-
价格:¥3600/¥2500
-
其他:
产品详情
-
产品描述:
This Human SALL4 ELISA Kit was designed for the quantitative measurement of Human SALL4 protein in serum, plasma, tissue homogenates, cell lysates. It is a Sandwich ELISA kit, its detection range is 37.5 pg/mL-2400 pg/mL and the sensitivity is 9.37 pg/mL.
-
别名:AA407717 ELISA Kit; AL022809 ELISA Kit; AW536104 ELISA Kit; C330011P20Rik ELISA Kit; C78083 ELISA Kit; C78563 ELISA Kit; dJ1112F19.1 ELISA Kit; DRRS ELISA Kit; HSAL4 ELISA Kit; Sal like 4 (Drosophila) ELISA Kit; Sal like 4 ELISA Kit; Sal like Protein 4 ELISA Kit; Sal-like protein 4 ELISA Kit; Sall4 ELISA Kit; SALL4_HUMAN ELISA Kit; Spalt like transcription factor 4 ELISA Kit; Tex20 ELISA Kit; Zinc finger protein 797 ELISA Kit; Zinc finger protein SALL4 ELISA Kit; ZNF797 ELISA Kit
-
缩写:SALL4
-
Uniprot No.:
-
种属:Homo sapiens (Human)
-
样本类型:serum, plasma, tissue homogenates, cell lysates
-
检测范围:37.5 pg/mL-2400 pg/mL
-
灵敏度:9.37 pg/mL
-
反应时间:1-5h
-
样本体积:50-100ul
-
检测波长:450 nm
-
研究领域:Epigenetics and Nuclear Signaling
-
测定原理:quantitative
-
测定方法:Sandwich
-
精密度:
Intra-assay Precision (Precision within an assay): CV%<8% Three samples of known concentration were tested twenty times on one plate to assess. Inter-assay Precision (Precision between assays): CV%<10% Three samples of known concentration were tested in twenty assays to assess. -
线性度:
To assess the linearity of the assay, samples were spiked with high concentrations of human SALL4 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay. Sample Serum(n=4) 1:1 Average % 89 Range % 85-92 1:2 Average % 102 Range % 97-107 1:4 Average % 90 Range % 85-95 1:8 Average % 97 Range % 91-103 -
回收率:
The recovery of human SALL4 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section. Sample Type Average % Recovery Range Serum (n=5) 101 101-107 EDTA plasma (n=4) 98 95-101 -
标准曲线:
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed. pg/ml OD1 OD2 Average Corrected 2400 2.782 2.799 2.791 2.658 1200 1.921 1.965 1.943 1.810 600 1.082 1.098 1.090 0.957 300 0.540 0.564 0.552 0.419 150 0.335 0.337 0.336 0.203 75 0.243 0.251 0.247 0.114 37.5 0.190 0.178 0.184 0.051 0 0.132 0.134 0.133 -
数据处理:
-
货期:3-5 working days
相关产品
靶点详情
-
功能:Transcription factor with a key role in the maintenance and self-renewal of embryonic and hematopoietic stem cells.
-
基因功能参考文献:
- an HBV-pSTAT3-SALL4-miR-200c axis regulates PD-L1 causing T cell exhaustion PMID: 29593314
- the TRIM21 knockdown increases SALL1 levels, indicating that TRIM21 degrades both SALL1 and SALL4. PMID: 29511085
- These data indicate that aberrantly expressed SALL4 in human choriocarcinoma cells may promote cell proliferation via beta-catenin/c-Myc pathway PMID: 28639477
- SALL4 was significantly upregulated in glioma tissues and cell lines, and an inverse correlation between miR-98 and SALL4 expression in glioma tissues was identified. PMID: 29436585
- TNFSF13, SPATC1L, SLC22A25 and SALL4 may thus be novel susceptibility loci for atrial fibrillation in the Japanese population PMID: 28849223
- Study showed significantly high expression of SALL4 mRNA in glioma specimens as compared to non-tumor samples using RT-PCR. Blocking SALL4 using SALL4-siRNA decreased proliferation of U87 and U251 cells, which was reversed by the addition of PTEN inhibitor phen (bpv). Furthermore, marked increase in PTEN mRNA and protein levels was seen in cells treated with siRNA-SALL4. PMID: 28887597
- SALL4 is a promising prognostic biomarker for cancer, and is appropriate for the assessment of cancer prognosis in the Chinese people. PMID: 28582841
- Our experimental data indicated that over expression of SALL4 was found in CRC and low expression of SALL4 was connected with high survival rate after surgery. Thus our study suggested that SALL4 could serve as a potential diagnostic and prognostic marker of CRC. PMID: 28869451
- SALL4 is a target gene of miR-181b in glioma.SALL4 is upregulated in glioma. PMID: 27938503
- SALL4 is a target gene of mir-98 in non-small cell lung cancer cells. PMID: 27938506
- miR-98 plays a suppressive role in the proliferation, migration, invasion and EMT of HCC cells, partly at least, via directly inhibition of SALL4. PMID: 27677076
- SALL4 immunopositivity is not a prognostic factor in Combined hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) (cHCC-CC); however, it is associated with alpha-fetoprotein, glypican 3 and EpCAM immunopositivity, indicating the mechanism of carcinogenesis. PMID: 26267070
- these data suggest that Bmi-1 could serve as a novel prognostic biomarker in pediatric primary acute lymphoblastic leukemia (ALL)and may be partially regulated by Sall4a. Our study also showed that Bmi-1 could serve as a new therapeutic target for the treatment of pediatric ALL. PMID: 28122538
- SALL4 overexpression is associated with neoplasms. PMID: 27007163
- Findings indicate that long-term exposure to IM results in dysregulation of stem cell renewal-regulatory Hippo (MST1/2)/YAP signaling, and that inhibition of miR-181a using a microRNA sponge inhibitor resulted in decreased transcription of SOX2 and SALL4. PMID: 28103766
- Study showed that SALL4 was overexpressed in a majority of human esophageal squamous cell carcinoma (ESCC) tissues and that aberrantly activated SALL4 may contribute to esophageal tumorigenesis by promoting malignant proliferation and inhibiting cell apoptosis, regulating esophageal squamous cell migration, invasion and cell cycle. PMID: 27329034
- Data show that SALL4 promotes the expression of Glut1 and open chromatin through a HP1alpha-dependent mechanism. PMID: 28759035
- Our report is the first description of structural eye defects associated with two missense variants in SALL4 inherited in trans; the absence of reported findings in both parents suggests that both sequence variants are hypomorphic mutations and that both are needed for the ocular phenotype. PMID: 27661448
- our study showed that SALL4 plays an important role in regulating the proliferation, migration, and invasion of osteosarcoma cells. PMID: 27983924
- The SALL4 - integrin alpha6 - integrin beta1 network promotes cell migration for metastasis via activation of focal adhesion dynamics in basal-like breast cancer cells. PMID: 27773610
- Coexpression of SALL4 with HDAC1 and/or HDAC2 was associated with PTEN underexpression and a poor prognosis in hepatocellular carcinoma. PMID: 28411180
- SALL4 has a negative impact in DNA damage repair, and support the model of dual functional properties of SALL4 in leukemogenesis through inhibiting DNA damage repair and promoting cell survival. PMID: 27132514
- demethylation of CpGs located within OCT4 and STAT3 cis-acting elements, downstream of SALL4 TSS, enables OCT4 and STAT3 binding, recruitment of BRG1, and enhanced RNA polymerase II elongation and SALL4 transcription PMID: 27797380
- SALL4 was expressed in 100% of choriocarcinomas and it was not detected in any placental site trophoblastic tumor and epithelioid trophoblastic tumor. PMID: 27068524
- SALL4 is useful for subtyping hepatoblastoma, and high SALL4 expression is associated with decreased survival in hepatoblastoma. PMID: 27252091
- expression detected in 36% of undifferentiated/dedifferentiated endometrial carcinomas, not other in high-grade endometrial carcinomas PMID: 28272224
- miR33b suppresses the proliferation and metastasis of hepatocellular carcinoma cells through the inhibition of SALL4 expression. PMID: 28026002
- this study demonstrates that miR-16 plays a suppressive role in regulating cell proliferation, migration and invasion, and EMT in glioma, at least in part by directly targeting SALL4. PMID: 27748823
- We evaluate the effects of siRNA-inhibited expression of the SALL4 gene on the proliferation, colony formation, and apoptosis of prostate cancer C4-2 cells. Silencing SALL4 expression by using siRNA technology inhibited the proliferation and colony formation of C4-2 cells, and promoted apoptosis likely mediated by Bcl-2 and Bax expression. PMID: 27323021
- the under-expression of SOX1 was associated significantly with SALL4 overexpression. This study was the first to evaluate SOX1 underexpression and its association with poor prognosis in esophageal squamous cell carcinoma. PMID: 27576349
- Hepatocellular carcinoma patients with higher expression levels of SALL4 and AFP have worse prognosis. PMID: 26973422
- Persistent expression of SALL4 in metastatic MGCTs resistant to chemoradiation also raises the possibility for targeted systemic therapy as the anti-SALL4 peptide continues to be developed PMID: 25906119
- SALL4 and beta-catenin were positively correlated in colorectal cancer. PMID: 26779651
- SALL4 was highly expressed and correlated with poor prognosis in SOC patients, promoting invasion and metastasis of OC cells. PMID: 26750614
- Study reports a novel heterozygous frameshift insertion in SALL4, c.410dupG (p.Gly138Argfs*43) segregating with Okihiro syndrome in a Brazilian pedigree with five affected individuals; the c.410dupG variant in SALL4 gene reported here is the cause of Okihiro syndrome without Duane anomaly, but with foot defect in one affected individual. PMID: 26791099
- By inhibition of SALL4 expression, the proliferation, invasiveness and drug resistance were dramatically reduced while apoptosis rate was up-regulated. PMID: 26617716
- SALL4 expression in squamous cell carcinoma of the esophagus may constitute a sign of dedifferentiation leading to poor patient prognosis PMID: 26818834
- SALL4 has an oncogenic role in intrahepatic cholangiocarcinoma PMID: 26317546
- review aims to summarize our current knowledge of SALL4, including a SALL4-based approach to classify and target cancers PMID: 26892498
- SALL4 could induce Epithelial-mesenchymal transition and resistance to antineoplastic drugs through the regulation of c-Myc. SALL4 and c-Myc may be novel therapeutic targets for endometrial cancer. PMID: 26407074
- The results show that miR-219-5p inhibited carcinogenesis of colon cancer by targeting oncogene Sall4 PMID: 26238082
- identifies the KRLR sequence as a bona fide nuclear localization signal for SALL4B. PMID: 24626181
- An atypical 0.73 MB microduplication of 22q11.21 and a novel SALL4 missense mutation associated with thumb agenesis and radioulnar synostosis. PMID: 25823593
- The mechanism through which miR-33b inhibits the stemness, migration and invasion of breast cancer cells is by targeting HMGA2, SALL4 and Twist1. PMID: 25919570
- Results indicate that SALL4 overexpression acts as a natural resistance factor and may be involved in the recurrence of lung cancer after adjuvant chemotherapy. PMID: 25646965
- Results indicated that the SALL4 may play an important role in progression, development and maintenance of glioma PMID: 25359397
- Despite moderate sensitivity, SALL4 expression may aid in distinguishing Malignant rhabdoid tumours from epithelioid sarcomas PMID: 24827994
- Aberrant SALL4 expression has been found in nearly all AML cases, whereas, in normal bone marrow and peripheral blood cells, its expression is only restricted to hematopoietic stem/progenitor cells. PMID: 25737450
- the evaluation of ERG and SALL4 immunoexpressions may be a useful diagnostic tool to distinguish epithelioid sarcoma, especially proximal type, from malignant rhabdoid tumor PMID: 25479928
- SALL4 has functional roles in metastasis and drug resistance in aggressive endometrial cancer PMID: 24336327
显示更多
收起更多
-
相关疾病:Duane-radial ray syndrome (DRRS); Oculootoradial syndrome (OORS)
-
亚细胞定位:Cytoplasm. Nucleus.
-
蛋白家族:Sal C2H2-type zinc-finger protein family
-
组织特异性:Expressed in testis. Constitutively expressed in acute myeloid leukemia (AML).
-
数据库链接:
Most popular with customers
-
Human Transforming Growth factor β1,TGF-β1 ELISA kit
Detect Range: 23.5 pg/ml-1500 pg/ml
Sensitivity: 5.8 pg/ml
-
-
-
Mouse Tumor necrosis factor α,TNF-α ELISA Kit
Detect Range: 7.8 pg/ml-500 pg/ml
Sensitivity: 1.95 pg/ml
-
-
-
-